The influence of bipolar disorder medication on sexual performance
DOI:
https://doi.org/10.12775/JEHS.2023.42.01.004Keywords
sexual funcion, sexual dysfunction, lithium, valproate, lamotrigine, quetiapineAbstract
Sexual performance is one of the key aspects of good quality of life, both in healthy people and patients suffering from various mental disorders. Besides many reasons causing poor sexual performance, like mental condition itself, medication can alter one's ability to achieve satisfaction in sex. Sexual dysfunction is listed among one of side effects of psychotropic medications. Aim of this work is to determine an influence of pharmacotherapy on sexual function in patients with bipolar disorder.
Results: Pharmacotherapy in patients suffering from bipolar disorder can cause a multitude of side effects, including malfunction in sexual performance. Extent of severity in poor sexual life depends on many factors among which are: type of drug taken, whether there are one or more drugs taken at the same time. Seems to be observed that quetiapine shows the least negative effect on sexual performance. Additionally, highest risk of sexual malfunction is observed in patients with polytherapy.
Conclusion: Besides topics investigated in the following research, there are additional factors like duration and severity of the disease, gender and age. There are many variables needed to be taken into consideration, but there is potential of choosing proper medication for a patient with least possible side effects and to allow them to perform more successful sex life, which directly corresponds with better quality of life.
References
Anderson, Ian M et al. “Bipolar disorder.” BMJ (Clinical research ed.) vol. 345 e8508. 27 Dec. 2012, doi:10.1136/bmj.e8508
Barata, Bernardo C. “Affective disorders and sexual function: from neuroscience to clinic.” Current opinion in psychiatry vol. 30,6 (2017): 396-401. doi:10.1097/YCO.0000000000000362
Sørensen, Thea et al. “Sexual distress and quality of life among women with bipolar disorder.” International journal of bipolar disorders vol. 5,1 (2017): 29. doi:10.1186/s40345-017-0098-0
Dell'Osso, Liliana et al. “Sexual dysfunctions and suicidality in patients with bipolar disorder and unipolar depression.” The journal of sexual medicine vol. 6,11 (2009): 3063-70. doi:10.1111/j.1743-6109.2009.01455.x
Vanwesenbeeck, Ine et al. “Associations between common mental disorders and sexual dissatisfaction in the general population.” The British journal of psychiatry: the journal of mental science vol. 205,2 (2014): 151-7. doi:10.1192/bjp.bp.113.135335
Kansy, Milena, et al. “Funkcjonowanie Seksualne W Chorobie Afektywnej Dwubiegunowej.” Seksuologia Polska, vol. 18, 2020. doi: 10.5603/SP.2020.0008
Geoffroy, P A et al. “Traitement du trouble bipolaire en phase maniaque : synthèse critique des recommandations internationales” [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines]. L'Encephale vol. 40,4 (2014): 330-7. doi:10.1016/j.encep.2013.10.007
Grover, Sandeep, et al. “Sexual Dysfunction in Clinically Stable Patients with Bipolar Disorder Receiving Lithium.” Journal of Clinical Psychopharmacology, vol. 34, no. 4, 2014, pp. 475–482., https://doi.org/10.1097/jcp.0000000000000131.
Elnazer, Hesham Y et al. “Lithium and sexual dysfunction: an under-researched area.” Human psychopharmacology vol. 30,2 (2015): 66-9. doi:10.1002/hup.2457
Grover, Sandeep et al. “Sexual dysfunction in clinically stable patients with bipolar disorder receiving valproate.” Indian journal of psychiatry vol. 63,4 (2021): 366-371. doi:10.4103/psychiatry.IndianJPsychiatry_205_20
Kaufman, Kenneth R et al. “Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review.” BJPsych open vol. 3,5 249-253. 4 Oct. 2017, doi:10.1192/bjpo.bp.117.005538
Erfurth, A et al. “Female genital disorder as adverse symptom of lamotrigine treatment. A serotoninergic effect?.” Neuropsychobiology vol. 38,3 (1998): 200-1. doi:10.1159/000026538
Nagaraj, Anil Kumar M et al. “A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.” Indian journal of psychiatry vol. 51,4 (2009): 265-71. doi:10.4103/0019-5545.58291
Kasper, Siegfried. “Treatment of depressive symptoms with quetiapine.” Expert review of neurotherapeutics vol. 3,4 (2003): 417-23. doi:10.1586/14737175.3.4.417
García-Blanco, Ana et al. “Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.” The journal of sexual medicine vol. 17,5 (2020): 930-940. doi:10.1016/j.jsxm.2020.01.032
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Małgorzata Chyćko, Julia Czarnota, Katarzyna Cichoń, Agata Kromer, Monika Łapaj, Magdalena Alicja Zapała, Agnieszka Środoń, Małgorzata Maria Cholewa, Agnieszka Gawryś, Joanna Wilk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 576
Number of citations: 0
